Clincosm LogoSign in Get a demo

urothelial carcinoma bladder

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Urothelial Carcinoma Bladder, Sperm Count, Low, Testis; Fibrosis Trial (Bacillus Calmette Guerin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • +2 more
  • Bacillus Calmette Guerin
  • (no location specified)
Jan 18, 2023

High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

Not yet recruiting
  • High Grade Urothelial Carcinoma
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 5, 2023

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,

Recruiting
  • Lung Cancer Non Small Cell
  • +2 more
  • IO102-IO103 in combination with pembrolizumab
  • Duarte, California
  • +18 more
Dec 15, 2022

Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma Bladder
  • PD-1 Inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

Recruiting
  • Bladder Cancer
  • +2 more
  • Tucson, Arizona
  • +76 more
Jul 13, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

Not yet recruiting
  • Bladder Cancer
  • +5 more
  • Bacillus Calmette-Guerin: Strain Russian BCG-I
  • Bacillus Calmette-Guerin: Strain TICE
  • (no location specified)
Apr 7, 2022

Urothelial Carcinoma Bladder Trial in Houston (drug, radiation, procedure)

Recruiting
  • Urothelial Carcinoma Bladder
  • Houston, Texas
    Houston Methodist Hospital
Feb 15, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102, TURBT)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Tucson, Arizona
  • +138 more
Nov 15, 2021

Bladder Cancer, Urothelial Carcinoma Bladder Trial in Mumbai (Adjuvant RT)

Recruiting
  • Bladder Cancer
  • Urothelial Carcinoma Bladder
  • Adjuvant RT
  • Mumbai, Maharashtra, India
    Tata Memorial Centre
Oct 6, 2021

Urothelial Carcinoma Bladder, Bladder Cancer Trial in Baltimore (Gemcitabine, Docetaxel)

Recruiting
  • Urothelial Carcinoma Bladder
  • Bladder Cancer
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 9, 2021

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Tucson, Arizona
  • +33 more
May 21, 2021

High-Risk Cancer, Urothelial Carcinoma Bladder Trial in Cairo (Adjuvant Radiotherapy)

Recruiting
  • High-Risk Cancer
  • Urothelial Carcinoma Bladder
  • Adjuvant Radiotherapy
  • Cairo, Egypt
    National Cancer Institute-Cairo University
Feb 8, 2021

Urothelial Carcinoma Bladder, Bladder Cancer Trial in Barcelona (En bloc transurethral resection of bladder tumor (TURBT),

Recruiting
  • Urothelial Carcinoma Bladder
  • Bladder Cancer
  • En bloc transurethral resection of bladder tumor (TURBT)
  • Conventional TURBT
  • Barcelona, Spain
    Fundacio Puigvert
Jan 13, 2021

Bladder Cancer, Urothelial Carcinoma Bladder Trial in Shenzhen (4SCAR-PSMA, 4SCAR-FRa)

Unknown status
  • Bladder Cancer
  • Urothelial Carcinoma Bladder
  • 4SCAR-PSMA
  • 4SCAR-FRa
  • Shenzhen, Gongdong, China
  • +1 more
Sep 18, 2019